Not yet recruitingPhase 3NCT06841614

EBOla Post-Exposure Prophylaxis

Studying Ebola hemorrhagic fever

Last synced from ClinicalTrials.gov May 8, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: ANRS, Emerging Infectious Diseases
Principal Investigator: Placide MBALA, MD, MSPH, PhD
INRB
Intervention: Ervebo(biological)
Enrollment: 160 enrolled
Eligibility: All sexes
Timeline: 2026 – 2028

Study locations (4)

National Institute for Biomedical Research (INRB), Kinshasa, Democratic Republic of the Congo
Guinea Centre for Research and Training in Infectious Diseases (CERFIG), Conakry, Guinea
National Public Health Institute of Liberia, Monrovia, Liberia
University of Sierra Leone College of Medicine and Allied Health Sciences, Freetown, Sierra Leone

Collaborators

Alliance for International Medical Action · Centre de Recherche et de Formation en Infectiologie de Guinée (CERFIG) · Medecins Sans Frontieres, Netherlands · Barcelona Institute for Global Health · University of Bordeaux · INSERM UMR S 1136 · Agence Nationale de Sécurité Sanitaire de Guinée (ANSS) · National Institute for Biomedical Research DRC · Cheikh Anta Diop University, Senegal · PACCI Program · The PANdemic preparedness plaTform for Health and Emerging infectious Response · University of Sierra Leone College of Medicine and Allied Health Sciences · National Public Health Institute of Liberia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06841614 on ClinicalTrials.gov

Other trials for Ebola hemorrhagic fever

Additional recruiting or active studies for the same condition.

See all trials for Ebola hemorrhagic fever →

← Back to all trials